Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Published Date: 17 Feb 2023

Antibiotic use linked to SJ syndrome and toxic epidermal necrosis, sulfonamides are worst culprits in new study...

Read Full News

Latest News

Ultrasound Increases Diagnostic Certainty of PsA Diagnosis

Preliminary findings of the PREDICT study suggest that the DUET Ultrasound Enthesitis Score may improve the confidence with which rheumatologists can diagnose psoriatic arthritis.

Adjuvant Radiotherapy Use Lags in Localized Merkel Cell

Adjuvant radiation therapy use has risen slightly overall in Merkel cell carcinoma but not for localized disease, study shows.

Italian Panel Pushes Biosimilars for IMID Care

An Italian expert panel is urging broader biosimilar use, faster access to new therapies, and stronger real-world tracking to improve sustainable care for inflammatory diseases.

Can Hypothalamic Damage Trigger Obesity

Hypothalamic damage disrupts hunger and satiety regulation, causing rapid weight gain, which often responds poorly to conventional lifestyle interventions.

Canada Wildfire Smoke Blankets US Midwest, Northeast

Heavy smoke from hundreds of wildfires in Canada enveloped a swath of the U.S. from the Midwest to the Northeast on Thursday, prompting warnings that residents should stay indoors.

Tissue Micro-Coring Improves Lower-Face Wrinkles

Tissue micro-coring improved the appearance of nasolabial folds, marionette lines, and perioral wrinkles in a small real-world study.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

Preliminary findings of the PREDICT study suggest that the DUET Ultrasound Enthesitis Score may improve the confidence with which rheumatologists can diagnose psoriatic arthritis.

Adjuvant radiation therapy use has risen slightly overall in Merkel cell carcinoma but not for localized disease, study shows.

An Italian expert panel is urging broader biosimilar use, faster access to new therapies, and stronger real-world tracking to improve sustainable care for inflammatory diseases.

Hypothalamic damage disrupts hunger and satiety regulation, causing rapid weight gain, which often responds poorly to conventional lifestyle interventions.

Heavy smoke from hundreds of wildfires in Canada enveloped a swath of the U.S. from the Midwest to the Northeast on Thursday, prompting warnings that residents should stay indoors.

Tissue micro-coring improved the appearance of nasolabial folds, marionette lines, and perioral wrinkles in a small real-world study.

News All Time

Panel Provides Consensus for Standardizing CSCC Imaging

Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.

Unapproved Peptides Common in Australia Despite Crackdown

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

FPT Plus Pulsed Dye Laser Effective for Port-Wine Birthmarks

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Skin Cancer: 5 Practical Tips for Earlier Detection

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

Dermatology AI Is Here. Now Comes the Hard Part

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

Tumor Biomarker Improves Surveillance of MCC Recurrences

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Candida auris Infections Persist, CDC Report Shows

Clinical and screening cases of C auris doubled between 2022 and 2024.

Patient Engagement With Dermatology Visit Notes Remains Low

Patient engagement with dermatology notes in the electronic patient portal varies by language, race, ethnicity, and clinician factors, study shows.

The Newest Frontier for GLP-1s: Clearing Skin Disease

Beyond weight loss, new research suggests these blockbuster drugs may target skin inflammation directly.

Strange Asymptomatic Rash Affects Young Man With Obesity for 2 Years

Diagnosis implicates high triglycerides as a contributor

Ambulatory Surgery May Be an Option for Troublesome HS

A wave of recently approved therapies has improved options for the control of hidradenitis suppurativa, but surgery remains a possible option for faster clinical benefit.

People With Atopic Eczema Stick With Dupilumab Longer

Real-world data shows dupilumab had higher 1-year treatment continuation than oral or subcutaneous methotrexate and ciclosporin.

Skip the Stairs: The Elevator Approach to Psoriasis

Rheumatologists and gastroenterologists don’t save their best drugs until last; neither should dermatologists.

Detecting Hidradenitis Suppurativa: Bringing the Patient's Voice to the Forefront

Detecting Hidradenitis Suppurativa: Bringing the Patient's Voice to the Forefront

Updates in Hidradenitis Suppurativa: Underlying Pathogenic Mechanisms and Novel Targeted Treatments

Updates in Hidradenitis Suppurativa: Underlying Pathogenic Mechanisms and Novel Targeted Treatments

An Expert TheraTalk on the Next Wave in Psoriasis Treatment: From Mechanistic Pathways to Clinical Practice

An Expert TheraTalk on the Next Wave in Psoriasis Treatment: From Mechanistic Pathways to Clinical Practice

Recommended News For You

When a Groundbreaking Cancer Therapy Causes Cancer.

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

Use of social media during pregnancy may increase depression.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

Study reveals increase in late-stage breast cancer diagnoses in US

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

After two years, a significant left nasal obstruction was finally diagnosed.

Recommended Articles For You

Survivorship Planning Beyond Active Cancer Care 

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key 

Prevention of Thrombotic Complications in High-Risk Patients 

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".

2.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

3.

FDA approves Blenrep for relapsed or refractory multiple myeloma

4.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

5.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

1.

The importance of understanding normal serum osmolality

2.

Innovative Approaches in Oncology for Modern Medicine

3.

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management

4.

The Future of Hematology: Innovations Every Doctor Should Know

5.

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part III

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

5.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot